BIOHM Health
PrivateLast Round
Series B
Apr 2, 2025
Total Funding Raised
$4.52M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BIOHM Health operates in Healthcare & Life Sciences and is based in Cleveland, Ohio. Its latest recorded funding round was a Series B round in April 2025.
BIOHM Health is a biotechnology company that develops microbiome-focused products, including probiotic supplements and gut health testing kits, designed to address the balance of bacteria and fungi in the digestive tract.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, D2C Brands, Healthcare Analytics
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting, Subscription SaaS, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BIOHM Health Comparables
Compare BIOHM Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Carbiotix | 82% | |
| Viome Life Sciences | 78% | |
| Brightseed | 76% |
For institutional investors. Book with your work email.
BIOHM Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 2, 2025 | ||||
| VC Round | Jan 12, 2023 | ||||
| Seed | Dec 19, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BIOHM Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vanterra Capital | Seed |
| Aztec Capital Management | VC Round |
| Sparkfood | Series B |
| Praesidium | Series B |
| Valley Growth Ventures | VC Round |
| Felton Group | VC Round |
| Healthcare Collaboration Fund | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 39% MoM, reaching 2.7K.
- Jul 24, 2026
Monthly visitors grew 36% MoM, reaching 1.9K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesNov 3, 2026
Biohm Technologies launches Ascomya, a fungal probiotic platform debuting with PK88, at SupplySide Global on Nov 3rd '26.
- launchesNov 3, 2026
Biohm Technologies launches Ascomya, a fungal probiotic platform debuting with PK88, its first commercially available pipeline ingredient, at SupplySide Global on Nov 3rd '26.
For institutional investors. Book with your work email.
BIOHM Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BIOHM Health's valuation, stock price, and market status.
Is BIOHM Health a public or private company?
BIOHM Health is a private company.
What is the current stock price of BIOHM Health?
BIOHM Health is a private company, so its shares have no public market price. Caplight tracks BIOHM Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BIOHM Health worth (valuation)?
Valuation information for BIOHM Health is not publicly available.
Can I buy BIOHM Health stock?
BIOHM Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BIOHM Health's last funding round?
BIOHM Health's most recent funding round was Series B on April 2, 2025.
Who are the main investors in BIOHM Health?
Key investors in BIOHM Health include Vanterra Capital, VTC Ventures.
Will BIOHM Health IPO soon?
No public IPO plans have been announced for BIOHM Health.
How can I track BIOHM Health secondary market activity?
Caplight tracks bids, offers, and trades in BIOHM Health's shares on secondary markets.